Chris Hourigan’s Post

🧬 Toulouse at the forefront of the fight against cancer! 🔬Working with IUCT-Oncopole, TSE economists are helping to maximize the benefits of medical advances 💊 Dive into our joint interview of Jean-Pierre DELORD, MD, PhD and Pierre Dubois, where they share their perspectives on the power of multidisciplinary partnerships! ▶️ Link to the interview in the comments below

Government Scientific Source is committed to advancing the frontiers of laboratory excellence, whether your research aims to combat cancer, revolutionize urban energy systems, or enhance lab sustainability. You may wonder, "How do we achieve this?" Our approach involves actively engaging with scientific communities wherever breakthroughs, challenges, and innovations are explored. One such pivotal organization is the American Association for Cancer Research (AACR), renowned as the oldest and most extensive professional association dedicated to cancer research, with a rich legacy spanning 117 years. We are thrilled to announce our participation in the April 5-10 AACR Annual Meeting at the San Diego Convention Center! This event provides a unique opportunity to glean insights from esteemed leaders who have paved the way for advancing cancer research. We eagerly anticipate joining this community of brilliant minds united by a profound mission: to prevent and cure cancer through robust efforts in research, education, communication, collaboration, advocacy, science policy, and funding. For further details about this event, please click here: https://lnkd.in/g6P3g2CD We hope to see you there! #CancerResearch #Research #CancerTreatment #SupplyChainSolutions #Cure

Please attend these two seminars to discuss how we make peer review more equitable and just.

Hi all- if you are a Spartan or know Spartan animal lovers, or Spartans working in the fight against cancer in the Bay Area, please share this today with your networks! We would love to have you join for our unique event this month on May 30th featuring our phenomenal faculty member Dr. Kurt Zinn. Dr. Zinn's innovative work is translational, connecting different fields of medicine. Find a snippet here from his Q and A with MSU Today: https://lnkd.in/e55GZrhb "Q: Which cancers are currently being studied through your biomedical research? A: We want to not just to kill the cancer, but to use it as a way to immunize the patient against the cancer. So, if cancer comes back in the future or if you don't get all of the cancer, you can still have a good prognosis. We currently have ongoing preclinical trials for ovarian cancer, plans for clinical trials for prostate cancer and will meet with the FDA soon to obtain guidance for conducting a funded clinical trial for bladder cancer using alpha-particle therapy."

"Unlocking implementation science" ✨Today, I gained valuable insights at the Children's Cancer Hospital Foundation 57357 webinar led by Dr. Maysam Homsi, DrPH, MPH, CCRP ✨I discovered the power of implementation science in bridging the gap between research and real-world practice. Learning about frameworks, strategies, and real-world applications has opened new perspectives on how to effectively translate research into actionable solutions. Excited to explore this field further!

UK Markey Cancer's Dr. Guan-Yu Xiao has secured a $747,000 grant from the National Cancer Institute to study lung cancer metastasis. His work focuses on lung adenocarcinoma, aiming to understand the cellular processes that drive cancer spread. This research could lead to new treatments and tackle resistance to current therapies. Dr. Xiao's findings on the EMT process and the Rab6A protein could revolutionize how we approach cancer treatment. Learn more about this groundbreaking study: https://bit.ly/3S4Nsse #CancerResearch #LungCancer #UKResearch #MedicalInnovation #Healthcare

Going to #AACR24 this year, April 5-10? Join our team at the American Association for Cancer Research (AACR) Annual Meeting. ✨ Aurélie QUENTIN, Frank Visser, Emmanuel Chereul and Romain Teinturier are looking forward to meeting you at booth #4117. Don't hesitate to contact them to set up a meeting and learn how ERBC Group can strategize your approach to make your cancer drug development a success. Don’t miss our poster presentations: 📅 Monday Apr 8, 2024, 9:00 AM - 12:30 PM. “The immuno-AVI-PDX, an innovative patient-derived xenograft model for preclinical immuno-oncology studies” 📅 Wednesday Apr 10, 2024, 9:00 AM - 12:30 PM. “Micro-implantation of patient tumor samples into the avian embryo, a fast and reliable alternative in vivo technology for preclinical studies on melanoma and follicular lymphoma” Don't miss this opportunity to connect oncology solutions, early! See you there! #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

#AACR24, I will be there! Join me at booth #4117 to learn how ERBC (European Research Biology Center) Group facilitates the evaluation of cancer drug candidates from preclinical proof of concept to market success. Let's network and explore opportunities together. See you there! 🚀 #lifescience #oncology #CRO #partnering #drugdevelopment 

Attending #AACR24? Want to learn more about how you can accelerate your oncology drug discovery with Oncofactory's embryonic xenograft models? Come and meet us at #booth4117 and attend our two poster presentations focusing on our innovative AVI-PDX model. Don’t hesitate to contact Romain Teinturier to arrange a meeting. #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

With the work Joan Chen, Ph.D does at Boundless Bio, every query is unique. As our Sr. Director, Bioinformatics, Joan is inspired by the creative challenges she encounters and appreciates the chance to be involved in impactful work for patients.   Joan is one of the many dedicated and unique BoundTowners on our team pushing to make steps in a new frontier in oncology. See more about her in her “Boundless Bio!”